HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular pharmacodynamics of emixustat in protection against retinal degeneration.

Abstract
Emixustat is a visual cycle modulator that has entered clinical trials as a treatment for age-related macular degeneration (AMD). This molecule has been proposed to inhibit the visual cycle isomerase RPE65, thereby slowing regeneration of 11-cis-retinal and reducing production of retinaldehyde condensation byproducts that may be involved in AMD pathology. Previously, we reported that all-trans-retinal (atRAL) is directly cytotoxic and that certain primary amine compounds that transiently sequester atRAL via Schiff base formation ameliorate retinal degeneration. Here, we have shown that emixustat stereoselectively inhibits RPE65 by direct active site binding. However, we detected the presence of emixustat-atRAL Schiff base conjugates, indicating that emixustat also acts as a retinal scavenger, which may contribute to its therapeutic effects. Using agents that lack either RPE65 inhibitory activity or the capacity to sequester atRAL, we assessed the relative importance of these 2 modes of action in protection against retinal phototoxicity in mice. The atRAL sequestrant QEA-B-001-NH2 conferred protection against phototoxicity without inhibiting RPE65, whereas an emixustat derivative incapable of atRAL sequestration was minimally protective, despite direct inhibition of RPE65. These data indicate that atRAL sequestration is an essential mechanism underlying the protective effects of emixustat and related compounds against retinal phototoxicity. Moreover, atRAL sequestration should be considered in the design of next-generation visual cycle modulators.
AuthorsJianye Zhang, Philip D Kiser, Mohsen Badiee, Grazyna Palczewska, Zhiqian Dong, Marcin Golczak, Gregory P Tochtrop, Krzysztof Palczewski
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 125 Issue 7 Pg. 2781-94 (Jul 01 2015) ISSN: 1558-8238 [Electronic] United States
PMID26075817 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • ATP-Binding Cassette Transporters
  • Abca4 protein, mouse
  • Enzyme Inhibitors
  • Free Radical Scavengers
  • Phenyl Ethers
  • Propanolamines
  • Schiff Bases
  • emixustat
  • Alcohol Oxidoreductases
  • Rdh8 protein, mouse
  • retinoid isomerohydrolase
  • cis-trans-Isomerases
  • Retinaldehyde
Topics
  • ATP-Binding Cassette Transporters (deficiency, genetics)
  • Alcohol Oxidoreductases (deficiency, genetics)
  • Animals
  • Catalytic Domain
  • Cattle
  • Crystallography, X-Ray
  • Enzyme Inhibitors (chemistry, metabolism, pharmacology)
  • Female
  • Free Radical Scavengers (chemistry, metabolism, pharmacology)
  • Macular Degeneration (drug therapy, metabolism)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Models, Molecular
  • Phenyl Ethers (chemistry, metabolism, pharmacology)
  • Propanolamines (chemistry, metabolism, pharmacology)
  • Retinal Degeneration (metabolism, pathology, prevention & control)
  • Retinaldehyde (chemistry, metabolism, toxicity)
  • Schiff Bases (metabolism)
  • Stereoisomerism
  • cis-trans-Isomerases (antagonists & inhibitors, chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: